ArticleArchives of medical science : AMS2020

RIVAroxaban TWICE daily for lysis of thrombus in the left atrial appendage in patients with non-valvular atrial fibrillation: the RIVA-TWICE study.

Roman Piotrowski et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.